Filing Details
CITIUS ONCOLOGY, INC. (NASDAQ:CTOR) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event.
8k filedNASDAQ:CTOR
CITIUS ONCOLOGY, INC. (CTOR) Reports Material Event to SEC
Filing Details CITIUS ONCOLOGY, INC. (NASDAQ:CTOR) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event. Market Context…
Market Context
CITIUS ONCOLOGY, INC.'s stock currently trades at $0.79 with a market capitalization of $96.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CITIUS ONCOLOGY, INC.'s stock.
All SEC filings for CITIUS ONCOLOGY, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CTOR Stock Page
Frequently Asked Questions
Where can I read CTOR's SEC filings?
Browse all filings on our CTOR SEC filings page.
What types of SEC filings does CITIUS ONCOLOGY, INC. file?
Public companies like CITIUS ONCOLOGY, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.